Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Canellos

Showing results (181-190 of 315) with videos related to

Pageof 32
Sort By:
Cancer Treatment Reports|February 1, 1979
High-dose methotrexate with leucovorin rescue in ovarian cancer: a phase II studyL M Parker, C T Griffiths, R A Yankee, et al.
Cancer Chemotherapy Reports|June 1, 1972
Clinical trials with 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) given intravenouslyC M Bagley, G P Canellos, R C Young, et al.
Cancer|February 11, 1975
Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapyP S Schein, B A Chabner, G P Canellos, et al.
Lancet (London, England)|June 16, 1973
Maintenance chemotherapy for advanced Hodgkin's disease in remissionR C Young, G P Canellos, B A Chabner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1985
Stage III Hodgkin's disease: improved survival with combined modality therapy as compared with radiation therapy aloneP Mauch, T Goffman, D S Rosenthal, et al.
Medicine|September 1, 1979
Microangiopathic hemolytic anemia and cancer: a reviewK H Antman, A T Skarin, R J Mayer, et al.
Lancet (London, England)|April 26, 1975
Second malignancies complicating Hodgkin's disease in remissionG P Canellos, J C Arseneau, V T DeVita, et al.
National Cancer Institute Monograph|October 1, 1975
Preliminary Results of trials of chemotherapy in advanced ovarian carcinomaR C Young, B A Chabner, S P Hubbard, et al.
Cancer|January 30, 2002
Lymphomas of the breast: primary and secondary involvementSusan M Domchek, Jonathan L Hecht, Mark D Fleming, et al.
Cancer Treatment Reports|March 1, 1978
Chemotherapy (cyclophosphamide, vincristine, and prednisone) versus radiotherapy (total body irradiation) for stage III-IV poorly differentiated lymphocytic lymphomaR E Johnson, G P Canellos, R C Young, et al.
Pageof 32

Showing results (181-190 of 315) with videos related to

Sort By:
Pageof 32
Cancer Treatment Reports|February 1, 1979
High-dose methotrexate with leucovorin rescue in ovarian cancer: a phase II studyL M Parker, C T Griffiths, R A Yankee, et al.
Cancer Chemotherapy Reports|June 1, 1972
Clinical trials with 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) given intravenouslyC M Bagley, G P Canellos, R C Young, et al.
Cancer|February 11, 1975
Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapyP S Schein, B A Chabner, G P Canellos, et al.
Lancet (London, England)|June 16, 1973
Maintenance chemotherapy for advanced Hodgkin's disease in remissionR C Young, G P Canellos, B A Chabner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1985
Stage III Hodgkin's disease: improved survival with combined modality therapy as compared with radiation therapy aloneP Mauch, T Goffman, D S Rosenthal, et al.
Medicine|September 1, 1979
Microangiopathic hemolytic anemia and cancer: a reviewK H Antman, A T Skarin, R J Mayer, et al.
Lancet (London, England)|April 26, 1975
Second malignancies complicating Hodgkin's disease in remissionG P Canellos, J C Arseneau, V T DeVita, et al.
National Cancer Institute Monograph|October 1, 1975
Preliminary Results of trials of chemotherapy in advanced ovarian carcinomaR C Young, B A Chabner, S P Hubbard, et al.
Cancer|January 30, 2002
Lymphomas of the breast: primary and secondary involvementSusan M Domchek, Jonathan L Hecht, Mark D Fleming, et al.
Cancer Treatment Reports|March 1, 1978
Chemotherapy (cyclophosphamide, vincristine, and prednisone) versus radiotherapy (total body irradiation) for stage III-IV poorly differentiated lymphocytic lymphomaR E Johnson, G P Canellos, R C Young, et al.
Pageof 32